CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Accelerating Clinical Trials
Advancing research with digital-first clinical trials
AI and clinical trials
Improving decentralised trials with mobile research nursing
The new era of global patient recruitment
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
AML cell therapy trials to watch in 2024 targeting GvHD
External controls can augment low populations in rare disease trials
Pipeline Moves: Approval prospects drop for Bayer’s cardiovascular drug after Phase III termination
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
BioVie reports protocol deviations in Phase III Alzheimer’s trial
4Moving Biotech shares innovative trial plans for GLP-1 osteoarthritis drug
Arrowhead seeks regulatory clearance for Type 1 myotonic dystrophy trial
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Candel downsizes to focus on oncolytic virus-based cancer therapies
External controls can augment low populations in rare disease trials
Royal Free London and UCL recruit patients for liver disease app trial
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Moderna mRNA patent revoked by EPO after Pfizer suit
Signal: Wegovy highlights UK’s complex relationship with private sector
Signal: Dutch health investor Gilde raises $804m for health startup fund
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
How to manage temperature-controlled shipments in unpredictable climate zones
How quality clinical monitoring oversight ensures the success of clinical trials
How to effectively incorporate PROMs in oncology trials
Events
Reports
Premium Insights
Newsletters
CT
All articles by Paul Dennis
Paul Dennis
Uncategorised
Why is the healthcare industry hesitant to join the metaverse?
Uncategorised
GlobalData Epidemiologist Report: Global Covid cases pass 96.2 million – Israel leads vaccinations
Uncategorised
International update: Global Covid infections pass 95.6 million – WHO slams vaccine profiteers
Uncategorised
How Biden’s $1.9t stimulus package will help tackle Covid
Uncategorised
GlobalData Epidemiologist Report: Global Covid deaths exceed 2 million as WHO asks for greater co-operation
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
Uncategorised
International update: Global Covid deaths pass 2 million – Norway investigates post-vaccination deaths
Uncategorised
International co-operation vital for Covid recovery
Uncategorised
GlobalData Epidemiologist Report: Grim milestone reached as global Covid deaths exceed 2 million
Uncategorised
International update: Global Covid deaths near 2 million as cases pass 93 million
Uncategorised
GlobalData Epidemiologist Report: Global Covid cases exceed 92 million – UK death count nears 85,000 – worst in Europe
View more
Most Popular
Why aren’t eligible sites being utilised in clinical trials?
Signal: US lays out plan to seize govt-funded drug patents to lower cost
BMS’s Opdivo meets co-primary endpoint in colorectal cancer trial
